News
Shire announces strong second quarter earnings, with product sales up by 16%, attributed largely by ADHD treatments, Vyvanse and Intuniv. Shire is on track to deliver double digit full year earnings growth, according to its recently released second…
Pfizer reports its second-quarter earnings, which, considering declining sales, are higher than analysts expected. Pfizer has announced its second-quarter financial results. The pharmaceutical company’s reported earnings for the…
David Cameron is to announce that the London 2012 anti-doping facility, provided by GSK for the Olympic Games, will be developed into the UK’s first phenome-research centre. Once the fun and games are all over, the London 2012 anti-doping facilities in Harlow will be developed into a world-class resource…
Vertex Pharmaceuticals announce massive sales increase as second-quarter financial results are revealed. Vertex Pharmaceuticals has announced its second-quarter consolidated financial results – and revealed that its sales…
Bayer has raised its 2012 annual forecasts after a good set of second-quarter sales results, including a 4% increase in pharmaceuticals, mainly achieved in the emerging markets. The Bayer Group has announced a core sales increase of 10% in the second quarter, pushing its earnings to…
Assay Depot has announced the launch of a virtual research laboratory, developed in partnership with global pharmaceutical company, AstraZeneca. Assay Depot Inc., the world’s largest online marketplace for pharmaceutical research services, has today announced it has launched…
Novartis’ drug, Afinitor, has been approved for treatment on women in the EU by the European Commission, following its approval by the US FDA last week. The European Commission has approved Afinitor (everolimus) tablets, made by pharma company Novartis, for the treatment…
Sanofi announces 6% increase in net sales in the second quarter, despite loss of exclusivity in some of its key products in the US. While AstraZeneca and GlaxoSmithKline announce their decreasing sales profits for the second quarter, Sanofi has announced it has…
The second-largest pharmaceutical company in the UK reveals its second quarter results have declined due to challenging market conditions and loss of product exclusivity. AstraZeneca has revealed its revenue for the second quarter is down by 18% to US $6.7million, but the company says…
